Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
about
MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma.The Role of MDM2 in Promoting Genome Stability versus Instability.Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1.Presence of stromal cells in a bioengineered tumor microenvironment alters glioblastoma migration and response to STAT3 inhibition.The p53 Pathway in Glioblastoma
P2860
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@en
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@nl
type
label
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@en
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@nl
prefLabel
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@en
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@nl
P2093
P2860
P50
P356
P1476
Combination therapy in a xenog ...... olomide by an MDM2 antagonist.
@en
P2093
Barbara J Bailey
Clark D Wells
David L Waning
David R Jones
Eric C Long
Haiyan Wang
Harlan E Shannon
Jacob A Eitel
Jann N Sarkaria
Jixin Ding
P2860
P304
P356
10.3171/2016.1.JNS152513
P407
P577
2016-05-13T00:00:00Z